Guest guest Posted June 10, 2011 Report Share Posted June 10, 2011 News 7 new results for hepatitis c New Drugs Promise Higher Cure Rates for Hepatitis CVoice of AmericaTelaprevir is one of two drugs expected to improve cure rates for people with hepatitis c. The US Food and Drug Administration has approved two new drugs - boceprevir and telaprevir - to treat hepatitis C, a virus that can cause liver damage and cancer ...See all stories on this topic » Analysis Finds Mortality From All Causes Higher Among Hepatitis C-InfectedInfection Control TodayAlthough liver-related mortality among those infected with hepatitis C is well-documented, little is known about deaths in these patients that are not related to liver problems. A new study published in Clinical Infectious Diseases sought to determine ...See all stories on this topic » Noninvasive Tests Reduce Need for Liver Biopsies in Hep CAIDSmeds.com HIV/AIDS Treatment NewsThe use of noninvasive alternatives to liver biopsies to assess liver disease in people with chronic hepatitis C is becoming increasingly more common and reliable in certain situations, according to an expert article published in the June issue of ...See all stories on this topic » No check on drug companies fleecing hepatitis patientsDAWN.comPESHAWAR, June 9: The multinational pharmaceutical companies have been fleecing the hepatitis C patients for the last several years and there is still no check on them, doctors and patients say. “Majority of hepatitis C patients needs Interferon ...See all stories on this topic » Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV7thSpace Interactive (press release)Background/Aim:Hepatitis C virus (HCV) is a major thread as almost 3% of the world's population (350 million individual) and 10% of the Pakistani population is chronically infected with this virus. RNA interference (RNAi), a sequence-specific ...See all stories on this topic » The making of a'bad girl'Toronto StarNow retired and dealing with hepatitis C, fibromyalgia and back problems, Bedford lives in an apartment in the Annex and, when needed, relies on supporters for help. She was born in Collingwood to a poor, mixed-race family and was removed from home by ...See all stories on this topic » Biolex funder takes VC haul to $190MBizjournals.comThe company's lead product candidate, Locteron, is a treatment for hepatitis C. The company states that worldwide sales of interferon products for the treatment of hepatitis C will approach $6 billion by 2016. Biolex also has a product candidate for ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.